Our Team

088a385d-8336-45cd-817a-0edfc22627f9

 

Board Chairman, Co-founder, and Scientific Advisor  |  Pediatric Vision Scanner Co-inventor

Dr. Hunter is Ophthalmologist-in-Chief and the Richard M. Robb Chair of Ophthalmology at Boston Children’s Hospital, President of the Children’s Hospital Ophthalmology Foundation, and Professor and Vice Chair of Ophthalmology at Harvard Medical School. 

Dr. Hunter earned a Bachelor of Science in electrical engineering from Rice University and a PhD (in Cell Biology) and MD from Baylor College of Medicine. After he completed an ophthalmology residency at Harvard’s Mass Eye and Ear Infirmary, he was a fellow at the Wilmer Ophthalmological Institute, Johns Hopkins University. He remained on faculty there as Associate Professor of Ophthalmology and of Biomedical Engineering until 2002, when he was selected as Ophthalmologist-in-Chief at Children’s.

During his time at Children’s, the Department of Ophthalmology has grown to become the largest pediatric ophthalmology department in the nation and perhaps the world, with 30 full-time faculty and pediatric subspecialists in nearly every aspect of ophthalmology, as well as 7 full-time research faculty.

Dr. Hunter’s clinical and research interests focus on strabismus and amblyopia. Dr. Hunter is former Editor-in-Chief of the Journal of the American Association of Pediatric Ophthalmology and Strabismus, and former Vice President of the 12,000-member Association for Research in Vision and Ophthalmology. He is also co-author of Last Minute Optics, now in its second edition, and Learning Strabismus Surgery. His clinical expertise includes evaluation and correction of strabismus (misaligned eyes) in adults and children, including highly complex cases, and treatment of pediatric cataracts with intraocular lens implantation. He is developing new approaches to strabismus surgery for complex cases, including sutures adjustable for several days after surgery, and superior rectus transposition (SRT) for Duane syndrome and sixth nerve palsy. He has been listed as a Best Doctor in Boston Magazine and Boston NowResearch | Clinical | Podcast

Chief Executive Officer and Co-founder

JustinMr. Shaka joined the company after serving as Financial Analyst to the Ophthalmology Foundation at Children's Hospital Boston, managing over $25M in research funds and endowments. While at Children's, he was also appointed to a 3-year post on the Editorial Administration of the Journal of AAPOS, the official publication of the American Association for Pediatric Ophthalmology and Strabismus, and the leading international peer-reviewed journal for scientific advances in pediatric ophthalmology, and he managed finances for a startup optical shop, which became profitable in its second year of operation.

Mr. Shaka received his MBA from the Tepper School of Business at Carnegie Mellon University, where he was elected President of the Entrepreneurship and Venture Capital Club, named Swartz Fellow of Entrepreneurship, and, in 2011, awarded the Canfield-Roseman Entrepreneur-of-the-Year. He was also an advisor and founding Board Member of IACT, a Pittsburgh, PA initiative to bring industry, academics, and clinicians together to encourage collaborative innovation within healthcare. Mr. Shaka received his bachelor's degree in Economics from the University of New Hampshire, and is a member of Phi Beta Kappa.

Chief Operations Officer and Board Director

Mr. Johnston has more than 30 years experience leading operations and manufacturing within medical device firms, including serving as the Senior Vice President of Operations at Smith & Nephew. Mr. Johnston also co-founded and served as Chairman of MassMEDIC, the Massachusetts medical device association bringing together manufacturers, suppliers, and non-profit groups.

In his role at REBIScan Mr. Johnston is actively leading contract manufacturing efforts so that the company's products can be built and deployed in a fiscally responsible and operationally timely manner.

Board Director

SteveMr. Fleck is President and CEO of Proximedics, an RFID tracking firm for the pharmaceutical industry. Previously, Mr. Fleck was Founder and Chief Technology Officer of ClearCount, a company specializing in operating room medical devices that is still in operation today. In this role, Mr. Fleck raised over $20.0MM in venture funding, built a successful product pipeline, and led the company, which was recently acquired by Stryker, to profitability. Mr. Fleck has also previously worked for Boehringer Laboratories, a medical device manufacturing firm in Philadelphia, in product development where he was responsible for several new products from conception to commercial release.

Mr. Fleck has an MBA from Carnegie Mellon University and a degree in Applied Physics and Bioengineering from Cornell University.

Optical Scientist

RobertMr. Winsor has over 20 years experience with the design, modeling, and fabrication of optical instruments. Mr. Winsor been primary or co-author on 8 patents issued, with another 4 patents pending.

ADVISORY BOARD

Scientific Advisory Board Chair | Pediatric Vision Scanner Co-inventor

SaurabhDr. Patel is a leading retina surgeon and President of the Florida Retina Center. Dr. Patel is a trained electrical engineer from Cornell University and earned his MD from Robert Wood Johnson Medical School of New Jersey. He received his Fellowship training at the Wilmer Eye Institute of Johns Hopkins University, and is a co-inventor of REBIScan’s retinal birefringence technology.

ADVISORY BOARD

Scientific Advisor

Lee

Dr. Lee Goldstein received a bachelor’s degree in humanities and biology from Columbia University and went on to complete his medical and doctoral training at Yale University. Dr. Goldstein completed an internal medicine internship and residency program in psychiatry at Harvard Medical School. His research focus has led to significant medical breakthroughs, including the first evidence of Alzheimer’s disease-associated amyloid pathology outside the brain as well as a new transcription factor that plays a crucial role in cellular differentiation within the lens and brain. His research has also identified the association between blast-induced head trauma and chronic traumatic encephalopathy (CTE). 
 
Dr. Goldstein has received honors from numerous organizations, including the Harvard Medical School, National Institute of Mental Health, National Alliance for Research on Schizophrenia and Affective Diseases, Alzheimer’s Association, the American Psychiatric Association, and the Optical Society of America. He is a Diplomate of the American Academy of Neurology and Psychiatry.

ADVISORY BOARD

Scientific Advisor

Howard

Dr. Ying is Assistant Professor of Ophthalmology at Boston Medical Center and an expert in amblyopia and traumatic brain injury. Dr. Ying earned a Bachelor of Science from Johns Hopkins University, and his MD and PhD from Washington University, in St. Louis. He joined the faculty at Johns Hopkins after completing his Fellowship at the Wilmer Eye Institute, where he served as Assistant Professor of Ophthalmology for over 10 years. Dr. Ying’s extensive peer-reviewed publications include leading papers in eye vergence and saccades.

ADVISORY BOARD

Quality Assurance & Regulatory Affairs Advisor

Mr. Ohanian is the former Vice President of Quality Assurance and Regulatory Affairs of Phillips Healthcare, with 35+ years experience in the QA/RA field.


ADVISORY BOARD

Marketing & Sales Advisor

Screenshot 2016-07-28 16.52.30Louise McDonald has extensive years of global business experience and a deep understanding of the complexities of the broader health care spectrum. She currently serves as President & Executive Vice President for the Healthcare, Government and Education business of Herman Miller, Inc., a leading global furnishings and solutions firm inspiring design to help people do great things. 

Previously, Louise served as Chief Marketing Officer for Welch Allyn, Inc. a global leader in medical diagnostic equipment. Prior to that, Louise was President of Welch Allyn’s International business and has worked in a variety of regions and roles during her career at Welch Allyn.

Louise currently serves on the Board of Directors of the Wall Family Enterprise, Madison WI., is a member of the Advisory Board of the Bonnie Wesorick Center, Grand Valley State University, and a board director of the National Kidney Foundation of Michigan. She earned her MBA at the Simon School of Business, University of Rochester and her BSc from McGill University. She is a strong supporter of the Women’s Business Leaders in Healthcare (WBL) and a charter member of the Professional Women in Healthcare (PWH).

ADVISORY BOARD

Marketing & Sales Advisor

JeffMr. Mortensen has over 30 years of business development, marketing and sales experience with an emphasis in launching new offerings and starting new businesses. He led all customer facing activities for PediaVision (acquired by Welch Allyn in 2014), launching the Spot Vision Screener in 2011. Mr. Mortensen has served as board member with Preserve Vision Florida (formerly Prevent Blindness Florida) since 2011. 


 

Contact Us

© REBIScan, Inc.

Boston, MA